TABLE 6.
Novel candidate genes for NMJ-related diseases in humans associated with endocytosis, synaptic vesicle formation and neurotransmitter release. All models are constitutive unless otherwise stated. Lethal phenotypes can have complete or incomplete penetrance. cKO, constitutive KO; SMA, spinal muscle atrophy.
Gene | Mouse model | Lethality a | References |
---|---|---|---|
Pre-synaptic terminal | |||
Dnajc5/Csp-⍺ | cKO | PD | Fernández-Chacón et al. (2004), Chandra et al. (2005), Ruiz et al. (2008), Rozas et al. (2012), Sharma et al. (2012), Zhang et al. (2012) |
Madd/Rab3 GEP | cKO | SD: V or NL | Tanaka et al. (2001) |
Nbea | cKO by random integration that in addition disturbs GH secretion causing dwarfism; cKO by gene trap | NL | Su et al. (2004), Medrihan et al. (2009), Nuytens et al. (2014) |
Pls3 | Overexpression in SMA models (Smn1−/−/Tg (SMN2)) | PD | Ackermann et al. (2013), McGovern et al. (2015), Hosseinibarkooie et al. (2016) |
Rims1 and Rims2 | cKO | NL | Schoch et al. (2002), Schoch et al. (2006) |
Stxbp5l/Tom2 | cKO | SD: V or PL | Geerts et al. (2015) |
Key: AD, allele or model-dependent; EL, embryonic lethality; NL, neonatal lethality; PD, premature death; PNL, perinatal lethality; PL, postnatal lethality; SD, strain-dependent; V, viability.